Prescription RequiredPALBOCICLIB 125 mg (Piclib) is a prescription targeted anticancer medicine used to treat hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It belongs to a class of medicines called CDK4/6 inhibitors and is usually prescribed in combination with hormone therapy. It helps slow the growth and spread of cancer cells and should be taken under the supervision of an oncologist.
| Generic name | PALBOCICLIB |
| Strength | 125 mg |
| Manufacturer | Hetero |
| Package size | 21 Capsules |
| Used for | Hormone receptor-positive, HER2-negative advanced or metastatic breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Palbociclib 125 mg works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which are proteins involved in cancer-cell growth and division. By blocking these proteins, palbociclib prevents cancer cells from progressing through the cell cycle, helping slow their growth and the progression of the disease.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
